Cargando…
Homocysteine‐Lowering Treatment and the Risk of Fracture: Secondary Analysis of a Randomized Controlled Trial and an Updated Meta‐Analysis
High plasma homocysteine is a risk factor for osteoporotic fractures. Several studies have assessed the possible preventive effect of homocysteine‐lowering B‐vitamin treatment on the risk of fracture with inconclusive results. In the current study, we include new results from the Aspirin Folate Poly...
Autores principales: | Garcia Lopez, Maria, Baron, John A, Omsland, Tone K, Søgaard, Anne Johanne, Meyer, Haakon E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139704/ https://www.ncbi.nlm.nih.gov/pubmed/30283911 http://dx.doi.org/10.1002/jbm4.10045 |
Ejemplares similares
-
The Association of Cold Ambient Temperature With Fracture Risk and Mortality: National Data From Norway—A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study
por: Dahl, Cecilie, et al.
Publicado: (2022) -
Characteristics of fallers who later sustain a hip fracture: a NOREPOS study
por: Søgaard, Anne Johanne, et al.
Publicado: (2022) -
Urban–Rural Differences in Hip Fracture Mortality: A Nationwide NOREPOS Study
por: Solbakken, Siri M, et al.
Publicado: (2019) -
Pakistanis living in Oslo have lower serum 1,25-dihydroxyvitamin D levels but higher serum ionized calcium levels compared with ethnic Norwegians. The Oslo Health Study
por: Holvik, Kristin, et al.
Publicado: (2007) -
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
por: Riska, Brit Solvor Lyse, et al.
Publicado: (2023)